Arcadia Biosciences, Inc. — Director's Dealing 2017

Jun 10, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2017-06-08

Reporting Person: Plavan Matthew T (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-08	Stock Option (right to buy)	$0.70	A	225000	Acquired	2027-06-08	Common Stock (225000)	Direct

Footnotes

F1: 25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service.